Goals of Skin Rejuvenation
Skin rejuvenation is a term referring to a variety of skin treatments addressing simultaneously different types of lesions.
The Skin Rejuvenation applicators are intended for the treatment of superficial benign pigmented and vascular lesions (such as telangiectasia, rosacea, poikiloderma and angioma), thus leading to skin rejuvenation.
The skin rejuvenation procedure provides a complete area treatment for the face, neck, chest, hands and arms. It could be also be employed on sporadic lesions anywhere in the body.
The skin rejuvenation application utilizes the elos technology which combines pulsed light optical energy in the visible and the near infrared range, and radio-frequency (RF) energy. Both optical and RF components are delivered to the skin as a combined pulse resulting in an efficient and safe treatment.
The optical energy targets the different chromophores. The SR applicator emits light in the wavelength range of 580-980 nm and superficial melanin and hemoglobin absorb well in this range. Thus target lesions such as lentigines and telangiectasias absorb light energy that is converted to heat, raising the temperature of the target tissue. Because the temperature is inversely proportional to the impedance, as temperature increases the impedance of the target structure decreases. RF energy flows to the heated area and elevates the temperature of the target structures to a level required for clearance.
RF energy is not absorbed by chromophores and is thus independent of skin color with no epidermal barrier to absorption as occurs with optical energy. Since the epidermis is constantly cooled it is protected from collateral damage. RF energy is effective in dermal layer remodeling, contributing to overall skin texture improvements. The system continually monitors skin temperature, which is inversely proportional to the measured impedance drop, reducing the possible incidence of side effects by preventing tissue overheating.
Skin rejuvenation treatment improves the appearance of photoaged skin by clearing the superficial pigmented and vascular lesions, thus improving the skin texture. However, the degree of improvement and the number of sessions required vary in patients with different photoaging severity.
Superficial pigmented lesions such as freckles, sun spots, age spots, sun damage, café au lait, and hyperpigmentation respond well to the Skin Rejuvenation treatment. Superficial melasma presents a special concern, as it is a condition controlled by hormones and may reoccur.
Aged skin with structural damage in the form of wrinkles and sagging may show a better general improvement when combining the Skin Rejuvination treatment with the Skin Tightening procedure.
Pre-Post Treatment Care
• The patient should avoid skin irritation or intentional skin tanning.
• The patient should discontinue any irritant topical agents for 2-3 days prior to treatment.
• The patient should arrive for treatment with clean skin. There should be no lotion, make-up, perfume, powder or bath/shower oil present on the skin in the area to be treated.
During the first two days following treatment, care should be taken to prevent trauma to the treated site.
The patient should use high factor sunscreen (30 SPF) and protect the treated area from sunlight. Tanning after treatment may cause hyperpigmentation.
The number of treatment sessions depends on the individual patient and typically varies between one and five sessions, every 3-4 weeks. Severely photoaged skin may need more sessions.
One touch-up session may be needed about 1-3 times a year, according to individual natural physiological processes of photoaging.
• Pacemaker or internal defibrillator.
• Superficial metal or other implants in the treatment area.
• Current or history of skin cancer, as well as any other type of cancer, or premalignant moles.
• Severe concurrent conditions, such as cardiac disorders.
• Pregnancy and nursing.
• Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
• Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus, Porphyria, and Epilepsy.
• Patients with a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regime.
• Poorly controlled endocrine disorders, such as diabetes or Poly Cystic Ovary.
• Any active condition in the treatment area, such as sores, psoriasis eczema, and rash.
• History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
• History of bleeding coagulopathies, or use of anticoagulants.
• Use of medication and herbs known to induce photosensitivity to light exposure at the wavelengths used, such as Isotretinoin (Accutane) within the last 6 months, tetracyclines, or St. John's Wort within the last 2 weeks.
• Facial laser resurfacing and deep chemical peeling within the last 3 months, if face is treated.
• Any surgical procedure in the treatment area within the last 3 months or before complete healing.
• Tattoo or permanent makeup in the treatment area.
• Excessively tanned skin from sun, tanning beds or tanning creams within last the 2 weeks.